Viewing Study NCT06131216


Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 11:49 AM
Study NCT ID: NCT06131216
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-11-14
First Post: 2023-11-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module